Pfizer (PFE) Current Taxes (2009 - 2026)

Pfizer has disclosed Current Taxes across 18 years of filings, most recently posting $3.1 billion for Q1 2026.

• In Q1 2026, Current Taxes rose 0.81% year-over-year to $3.1 billion; the TTM figure through Mar 2026 stood at $3.1 billion (up 0.81% YoY), while the FY2025 annual figure was $3.1 billion, up 6.63% from the prior year.
• Current Taxes rose to $3.1 billion in Q1 2026, from $3.1 billion in the prior quarter.
• Over the last five years, Current Taxes for PFE reached as high as $3.8 billion in Q3 2025 and fell as low as $1.6 billion in Q4 2022.
• The 5-year median for Current Taxes is $3.1 billion (2022), against an average of $2.9 billion.
• Annual changes were most pronounced in 2022 — Current Taxes jumped 126.77% — and 2023, when it tumbled 38.2%.
• A 5-year view of Current Taxes shows it stood at $1.6 billion in 2022, then jumped by 48.02% to $2.3 billion in 2023, then rose by 23.88% to $2.9 billion in 2024, then increased by 6.63% to $3.1 billion in 2025, then rose by 0.87% to $3.1 billion in 2026.
• According to Business Quant data, Current Taxes over the past three periods registered $3.1 billion, $3.1 billion, and $3.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.